alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
OF HEALTH AND HUMAN SERVICES

ministration

th the National Council on

on and Education

UMER SAFETY GUIDE

The Internet has changed the way we live,work and shop. The growth of the Internethas made it possible to compare prices andbuy products without ever leaving home.But when it comes to buying medicineonline, it is important to be very careful.Some websites sell medicine that may not besafe to use and could put your health at risk.

Buying your medicineonline can be easy.Just make sure you do it safely.

• aren’t U.S. state-licensed pharmacies or

aren’t pharmacies at all

• may give a diagnosis that is not correct

and sell medicine that is not rightfor you or your condition

• won’t protect your personal informationSome websites that sell medicine:

Some medicines sold online:• are fake (counterfeit or “copycat” medicines)

• are too strong or too weak• have dangerous ingredients• have expired (are out-of-date)• aren’t FDA-approved (haven’t been checked

for safety and effectiveness)

• aren’t made using safe standards• aren’t safe to use with other medicine or

products you use

• aren’t labeled, stored, or shipped correctly

g Prescription

cine Online:
source to

t’s safe

ebsite is a

pharmacy

in the

Pharmacies

sts in the

are licensed

ard of

r state board

an tell you if a website is a

pharmacy, is in good standing,

in the United States. Find a list

s of pharmacy on the National

Boards of Pharmacy (NABP)

ww.nabp.info

professional association of the

f pharmacy. It has a program to

ome of the pharmacies that

sell medicine online. Internet

display the seal of this program

cked to make sure they meet

ral rules. For more on this

list of pharmacies that display

ternet

tice SitesTM

eal), go to

o

1 be located in the United States

and licensed by the state board ofpharmacy where the website isoperating (check www.nabp.info fora list of state boards of pharmacy)

2 have a licensed pharmacist to answer

your questions

3 require a prescription from your

doctor or other health care professionalwho is licensed in the United States towrite prescriptions for medicine

4 have a way for you to talk to a person

if you have problems

se tips will help protect you

Be sure your privacy is protected• Look for privacy and security policies that

are easy-to-find and easy-to-understand.

• Don’t give any personal information

(such as social security number, creditcard, or medical or health history),unless you are sure the website willkeep your information safe and private.

• Make sure that the website will not sell

your personal information, unless youagree.

Protect yourself and others• Report websites you are not sure of, or

if you have complaints about a site.

Go to www.fda.gov/buyonline and click

on “Notify FDA about problem websites.”

if you buy medicines online:

Look for websites with practices that protect you

A safe website should:

Buying your medicine online can be easy.Just make sure you do it safely. 

oducts Online,” at 

®
No. 65282.

#### Aut Customs Brokers, Inc. *v.*United States,

protest 60/18316 (New York).

Opinion by

Johnson, J.

Since the protest was filed more than 60 days after liquidation, it was dismissed as untimely, by virtue of section 514, Tariff Act of 1930.
No. 56217.

protest 172438-K (New York).

#### Ali Shabbir India Co., Inc. *v.*United States,

Opinion by

Mollison, J.

Following the authorities cited in Abstract 15400 the court dismissed the protest.
No. 52400.

protests 125865-K, etc. (New York).

#### Biological Raw Products Co. et al. *v.*United States,

Opinion by

Cole, J.

The protests were dismissed.
<TABLE> <S> <C>

<ARTICLE>      5
<LEGEND>       THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
               FROM THE ACCOMPANYING CONDENSED CONSOLIDATED FINANCIAL
               STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
               SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                                     <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       OCT-30-1999
<PERIOD-START>                          NOV-01-1998
<PERIOD-END>                            JAN-30-1999
<CASH>                                     12,478
<SECURITIES>                               37,070
<RECEIVABLES>                              13,513
<ALLOWANCES>                                    0
<INVENTORY>                                 4,206
<CURRENT-ASSETS>                           68,890
<PP&E>                                      5,550
<DEPRECIATION>                                  0
<TOTAL-ASSETS>                             84,636
<CURRENT-LIABILITIES>                      20,358
<BONDS>                                         0
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<COMMON>                                   90,516
<OTHER-SE>                                (26,238)
<TOTAL-LIABILITY-AND-EQUITY>               84,636
<SALES>                                    20,233
<TOTAL-REVENUES>                           20,233
<CGS>                                       8,934
<TOTAL-COSTS>                               8,934
<OTHER-EXPENSES>                           12,473
<LOSS-PROVISION>                                0
<INTEREST-EXPENSE>                              0
<INCOME-PRETAX>                              (584)
<INCOME-TAX>                                   95
<INCOME-CONTINUING>                          (679)
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                                 (679)
<EPS-PRIMARY>                              ($0.10)
<EPS-DILUTED>                              ($0.10)

        

</TABLE>
No. 55042.

#### European Chemical & Metal Co. *v.*United States,

protest 151782-K (New York).

Opinion by

Ekwall, J.

Following the authorities cited in Abstract 15400 the court dismissed the protest.
**Exhibit
      32.2**




CERTIFICATIONS
      PURSUANT TO 18 U.S.C. SECTION 1350





Pursuant
      to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
      section 1350, chapter 63 of Title 18, United States Code), the undersigned
      officers of SHINE MEDIA ACQUISITION CORP., a Delaware corporation (the
      "Company"), does hereby certify with respect to the Annual Report of the Company
      on Form 10-K/A1 for the year ended December 31 2007 as filed with the Securities
      and Exchange Commission (the "10-K Report") that:





(1)
      the
      10-K Report fully complies with the requirements of Section 13(a) or 15(d)
      of
      the Securities Exchange Act of 1934; and





(2)
      the
      information contained in the 10-K Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





Date:
              August 21, 2008
            SHINE
              MEDIA ACQUISITION CORP.By:
            /S/
                Hock S. OngHock
                S. OngChief
                Financial Officer
Artisoft, Inc. and Subsidiaries
             EXHIBIT 11. COMPUTATION OF NET INCOME (LOSS) PER SHARE
                    (in thousands, except per share amounts)
<TABLE>
<CAPTION>
                                                            Three Months Ended      Nine-months Ended
                                                                March  31,              March  31,
                                                             1998        1997        1998       1997
                                                           --------    --------    --------   --------
<S>                                                        <C>         <C>         <C>        <C>      
Net income (loss)                                          $   (162)   $ (3,663)   $  1,374   $ (8,998)
                                                           ========    ========    ========   ========
                                                           
                                                           
                                                           
Weighted average common shares outstanding                   14,539      14,546      14,529     14,531
                                                           
   Common equivalent shares representing                   
   shares issuable upon exercise of stock                  
   options (1)                                                  N/A         N/A          47        N/A
                                                           --------    --------    --------   --------
                                                           
       Diluted weighted average shares outstanding           14,539      14,546      14,576     14,531
                                                           ========    ========    ========   ========
                                                           
                                                           
Basic net income (loss) per share                          $   (.01)   $   (.25)   $    .09   $   (.62)
                                                           ========    ========    ========   ========
Diluted net income (loss) per share                        $   (.01)   $   (.25)   $    .09   $   (.62)
                                                           ========    ========    ========   ========
</TABLE>                                                
------
Notes:
(1)   Amount calculated using the treasury stock method and fair market values
From: vdhoek@fastmail.fm

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 7:37:47 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Dan VandenHoek

Wyoming, MI 49519
# Official Journal L 210/2011

| | ISSN 1725-2555
  doi:10.3000/17252555.L_2011.210.eng |
| --- | --- |
| Official Journal
  of the European Union | L 210 |
| | |
| English edition | Legislation | Volume 5417 August 2011 |

ISSN 1725-2555

doi:10.3000/17252555.L_2011.210.eng

Official Journal

of the European Union

L 210

English edition

Legislation

Volume 5417 August 2011

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | DECISIONS |
| | | 2011/501/EU |
| | * | Commission Decision of 23 February 2011 on State aid C 58/06 (ex NN 98/05) implemented by Germany for Bahnen der Stadt Monheim (BSM) and Rheinische Bahngesellschaft (RBG) in the Verkehrsverbund Rhein-Ruhr
  (notified under document C(2011) 632)

   (1) | 1 |

Contents

II   Non-legislative acts

page

DECISIONS

2011/501/EU

*

Commission Decision of 23 February 2011 on State aid C 58/06 (ex NN 98/05) implemented by Germany for Bahnen der Stadt Monheim (BSM) and Rheinische Bahngesellschaft (RBG) in the Verkehrsverbund Rhein-Ruhr
  (notified under document C(2011) 632)

   (1)

(notified under document C(2011) 632)

1

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Scenario Name,Date,Real GDP growth,Nominal GDP growth,Real disposable income growth,Nominal disposable income growth,Unemployment rate,CPI inflation rate,3-month Treasury rate,5-year Treasury yield,10-year Treasury yield,BBB corporate yield,Mortgage rate,Prime rate,Dow Jones Total Stock Market Index (Level),House Price Index (Level),Commercial Real Estate Price Index (Level),Market Volatility Index (Level)
Supervisory Baseline,2019 Q1,2.2,4.2,2.8,4.2,3.7,1.5,2.5,2.8,2.9,4.6,4.5,5.5,26025.8,206.5,292.8,28.3
Supervisory Baseline,2019 Q2,2.5,4.8,2.3,4.5,3.6,2.3,2.6,2.9,3.0,4.8,4.6,5.6,26366.9,207.8,296.4,27.0
Supervisory Baseline,2019 Q3,2.2,4.4,2.3,4.4,3.6,2.3,2.7,3.0,3.1,4.9,4.6,5.7,26686.8,209.1,300.2,25.3
Supervisory Baseline,2019 Q4,2.0,4.2,2.2,4.3,3.6,2.3,2.8,3.0,3.2,4.9,4.7,5.8,26998.3,210.4,303.9,24.5
Supervisory Baseline,2020 Q1,1.7,4.0,2.1,4.3,3.6,2.4,2.8,3.0,3.2,4.9,4.7,5.8,27298.7,211.7,307.8,23.9
Supervisory Baseline,2020 Q2,1.6,4.0,2.1,4.0,3.6,2.1,2.8,3.0,3.2,4.9,4.7,5.8,27603.1,213.0,311.6,23.5
Supervisory Baseline,2020 Q3,1.5,3.7,1.9,4.0,3.7,2.2,2.8,3.0,3.2,4.9,4.7,5.8,27894.4,214.3,315.6,23.7
Supervisory Baseline,2020 Q4,1.6,3.8,1.9,3.8,3.8,2.1,2.8,3.1,3.2,4.9,4.7,5.8,28192.7,215.7,319.5,23.9
Supervisory Baseline,2021 Q1,2.2,4.3,2.3,4.4,3.9,2.2,2.8,3.3,3.4,5.2,4.9,5.8,28528.5,217.3,321.9,24.6
Supervisory Baseline,2021 Q2,2.0,4.1,2.2,4.2,4.0,2.2,2.8,3.3,3.5,5.1,5.0,5.8,28857.6,219.0,324.3,23.8
Supervisory Baseline,2021 Q3,2.0,4.1,2.2,4.2,4.0,2.2,2.8,3.4,3.5,5.2,5.0,5.8,29190.5,220.6,326.8,23.7
Supervisory Baseline,2021 Q4,2.0,4.1,2.2,4.2,4.0,2.2,2.8,3.4,3.5,5.2,5.0,5.8,29527.2,222.3,329.3,23.6
Supervisory Baseline,2022 Q1,2.0,4.1,2.2,4.2,4.1,2.2,2.8,3.4,3.6,5.2,5.1,5.8,29867.5,223.9,331.7,23.6
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1,000  
<CURRENCY>                    U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                JUN-30-1998
<PERIOD-START>                                   JUL-01-1997
<PERIOD-END>                                     SEP-30-1997
<EXCHANGE-RATE>                                            1 
<CASH>                                                13,337 
<SECURITIES>                                               0 
<RECEIVABLES>                                          8,662 
<ALLOWANCES>                                               0 
<INVENTORY>                                            1,786 
<CURRENT-ASSETS>                                      26,973 
<PP&E>                                                 7,895 
<DEPRECIATION>                                         5,322 
<TOTAL-ASSETS>                                        32,111 
<CURRENT-LIABILITIES>                                  8,687 
<BONDS>                                                    0 
<PREFERRED-MANDATORY>                                      0 
<PREFERRED>                                                0 
<COMMON>                                                 278 
<OTHER-SE>                                            22,564 
<TOTAL-LIABILITY-AND-EQUITY>                          32,111 
<SALES>                                                6,725 
<TOTAL-REVENUES>                                       6,838 
<CGS>                                                  1,454 
<TOTAL-COSTS>                                          1,454 
<OTHER-EXPENSES>                                       5,146 
<LOSS-PROVISION>                                           0 
<INTEREST-EXPENSE>                                         0 
<INCOME-PRETAX>                                          238 
<INCOME-TAX>                                               0 
<INCOME-CONTINUING>                                        0 
<DISCONTINUED>                                             0 
<EXTRAORDINARY>                                            0 
<CHANGES>                                                  0 
<NET-INCOME>                                             238   
<EPS-PRIMARY>                                            .02 
<EPS-DILUTED>                                            .02 
                                                         

</TABLE>
EXHIBIT
32.1




CERTIFICATION
PURSUANT TO


18 U.S.C.
1350


(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002)




Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer
of Pet DRx Corporation (the “Company”), does hereby certify, to the best of his
knowledge and belief that:




(1) The
Annual Report on Form 10-K for the year ended December 31, 2007 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.




Date:
April 4, 2008








/s/ Steven T.
      JohnsonSteven
      T. JohnsonPresident
      and Chief Operating Officer
              (Principal
      Executive Officer)




The
foregoing certification is being furnished to the Securities and Exchange
Commission as an exhibit to the Form 10-K and shall not be considered filed as
part of the Form 10-K.
Before the Third Division,

February 13, 1968

No. P68/60.

protest 66/3096 (New York).

No. P68/61.

protest 66/3107 (New York).

#### Trans World Airlines, Inc. *v.*United States, Trans World Airlines, Inc. *v.*United States,

Landis, J.

In accordance with stipulation of counsel that the merchandise covered by the foregoing protests consists of certain airplane parts, which are manufactures of the United States, exported without drawback, and returned without having been advanced hi value or improved in condition by any process of manufacture or other means and that the applicable customs regulations have been complied with, the claim of the plaintiff was sustained. *Bertrand*Freres, Inc., *et al.*v. *United States*(47 Cust. Ct. 155, C.D. 2296).
```

[Federal Register Volume 76, Number 213 (Thursday, November 3, 2011)]
[Notices]
[Page 68256]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28622]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 7676]

Culturally Significant Objects Imported for Exhibition 
Determinations: ``Shapeshifting: Transformations in Native American 
Art''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, Delegation of Authority No. 236-3 
of August 28, 2000 (and, as appropriate, Delegation of Authority No. 
257 of April 15, 2003), I hereby determine that the objects to be 
included in the exhibition ``Shapeshifting: Transformations in Native 
American Art,'' imported from abroad for temporary exhibition within 
the United States, are of cultural significance. The objects are 
imported pursuant to loan agreements with the foreign owners or 
custodians. I also determine that the exhibition or display of the 
exhibit objects at the Peabody Essex Museum, Salem, MA, from on or 
about January 14, 2012, until on or about April 29, 2012, and at 
possible additional exhibitions or venues yet to be determined, is in 
the national interest. I have ordered that Public Notice of these 
Determinations be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Julie Simpson, Attorney-Adviser, 
Office of the Legal Adviser, U.S. Department of State (telephone: (202) 
632-6467). The mailing address is U.S. Department of State, SA-5, L/PD, 
Fifth Floor (Suite 5H03), Washington, DC 20522-0505.

     Dated: October 28, 2011.
J. Adam Ereli,
Principal Deputy Assistant Secretary, Bureau of Educational and 
Cultural Affairs, Department of State.
[FR Doc. 2011-28622 Filed 11-2-11; 8:45 am]
BILLING CODE 4710-05-P
```
Before the First Division,

June 19, 1967

No. P67/200.

#### Polk’s Model Craft Hobbies, Inc. *v.*United States,

protests 63/8121, etc. (Los Angeles).

Oliver, J.

In accordance with stipulation of counsel that the merchandise covered by the foregoing protests consists of miniature motors the same in all material respects as those the subject of *James G. Wiley Co., a/c Ungar Electric Tools*v. *United States*(49 Cust. Ct. 199, Abstract 66961); *H. H. Elder & Co. and T.V. Promotions Import Co. et al.*v. *United States*(48 Cust. Ct. 397, Abstract 66651); and *Polks Model Craft Hobbies, Inc., and Meadows Wye & Co., Inc.*v. *United States*(38 Cust. Ct. 422, Abstract 60545), the claim of the plaintiff was sustained.
Exhibit 23.1
 
 
 
 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 We have issued our reports dated March 14, 2011 with respect to the consolidated financial statements and schedules and internal control over financial reporting included in the Annual Report of Resource Capital Corp. and subsidiaries on Form 10-K for the year ended December 31, 2010.  We hereby consent to the incorporation by reference of said reports in the Registration Statements of Resource Capital Corp. on Forms S-3 (File No. 333-151621, effective on June 12, 2008 and File No. 333-146626, effective on May 29, 2008) and Form S-8 (File No. 333-151622, effective on June 12, 2008).
 
 /s/ Grant Thornton LLP
 
 Philadelphia, Pennsylvania
 March 14, 2011